Eledon Pharmaceuticals, Inc. Total Liabilities and Equity
Eledon Pharmaceuticals, Inc. (ELDN) had Total Liabilities and Equity of $126.09 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $126.09M.
- 2026-03-31: Liabilities and Equity $146.67M.
- 2025-12-31: Liabilities and Equity $169.01M.
- 2025-09-30: Liabilities and Equity $129.86M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $126.09M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $146.67M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $169.01M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $129.86M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $144.91M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $161.31M 10-Q/A · filed 2025-08-14 | |
| 2024-12-31 | $177.41M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $114.58M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $120.48M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $80.82M 10-Q/A · filed 2024-08-19 | |
| 2023-12-31 | $89.07M 10-K/A · filed 2025-08-14 | |
| 2023-09-30 | $96.07M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $106.78M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $82.31M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $92.79M 10-K/A · filed 2024-08-19 | |
| 2022-09-30 | $149.59M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $154.71M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $161.38M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $170.55M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $177.17M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $184.31M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $191.68M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $197.19M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $192.59M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $10.50M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $13.72M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $10.93M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $15.22M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $18.22M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $13.45M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $17.03M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $19.93M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $22.96M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $25.92M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $20.89M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $23.02M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $26.84M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $25.83M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $1.20M 10-K · filed 2018-04-02 | $29.76M 10-K · filed 2017-03-03 |
| 2016-09-30 | $36.72M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $46.86M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $57.71M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $67.97M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $77.61M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $87.41M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $96.65M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $107.74M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $106.98M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | $32.29M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |